Report Overview
Non-Opioid Pain Treatment address acute and chronic pain and regulatory issues faced by healthcare professionals.
The global Non-Opioid Pain Treatment market size was estimated at USD 19550 million in 2023 and is projected to reach USD 74347.89 million by 2032, exhibiting a CAGR of 16.00% during the forecast period.
North America Non-Opioid Pain Treatment market size was estimated at USD 6587.24 million in 2023, at a CAGR of 13.71% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Non-Opioid Pain Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non-Opioid Pain Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non-Opioid Pain Treatment market in any manner.
Global Non-Opioid Pain Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Allergan PLC
Canopy Growth
Medical Marijuana Inc.
Panag Pharma Inc.
Tilray
Aphria Inc.
Bedrocan
Cara Therapeutics
Centrexion Therapeutics
CHT Medical
Cronos Group
GW Pharmaceuticals
Medropharm Gmbh
US Worldmeds LLC
Market Segmentation (by Type)
Medical Cannabis Treatment
Capsaicin-derived Treatment
Menthol-containing Treatment
Omega 3 fatty acid-containing Treatment
Botulinum Toxins
Market Segmentation (by Application)
Orthopaedic and Musculoskeletal Pain
Neuropathic Pain
Cancer Pain
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Non-Opioid Pain Treatment Market
Overview of the regional outlook of the Non-Opioid Pain Treatment Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Non-Opioid Pain Treatment
1.2 Key Market Segments
1.2.1 Non-Opioid Pain Treatment Segment by Type
1.2.2 Non-Opioid Pain Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Non-Opioid Pain Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Non-Opioid Pain Treatment Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Non-Opioid Pain Treatment Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Non-Opioid Pain Treatment Market Competitive Landscape
3.1 Global Non-Opioid Pain Treatment Sales by Manufacturers (2019-2025)
3.2 Global Non-Opioid Pain Treatment Revenue Market Share by Manufacturers (2019-2025)
3.3 Non-Opioid Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Non-Opioid Pain Treatment Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Non-Opioid Pain Treatment Sales Sites, Area Served, Product Type
3.6 Non-Opioid Pain Treatment Market Competitive Situation and Trends
3.6.1 Non-Opioid Pain Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Non-Opioid Pain Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Non-Opioid Pain Treatment Industry Chain Analysis
4.1 Non-Opioid Pain Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Non-Opioid Pain Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Non-Opioid Pain Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-Opioid Pain Treatment Sales Market Share by Type (2019-2025)
6.3 Global Non-Opioid Pain Treatment Market Size Market Share by Type (2019-2025)
6.4 Global Non-Opioid Pain Treatment Price by Type (2019-2025)
7 Non-Opioid Pain Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-Opioid Pain Treatment Market Sales by Application (2019-2025)
7.3 Global Non-Opioid Pain Treatment Market Size (M USD) by Application (2019-2025)
7.4 Global Non-Opioid Pain Treatment Sales Growth Rate by Application (2019-2025)
8 Non-Opioid Pain Treatment Market Consumption by Region
8.1 Global Non-Opioid Pain Treatment Sales by Region
8.1.1 Global Non-Opioid Pain Treatment Sales by Region
8.1.2 Global Non-Opioid Pain Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Non-Opioid Pain Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-Opioid Pain Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non-Opioid Pain Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-Opioid Pain Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-Opioid Pain Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Non-Opioid Pain Treatment Market Production by Region
9.1 Global Production of Non-Opioid Pain Treatment by Region (2019-2025)
9.2 Global Non-Opioid Pain Treatment Revenue Market Share by Region (2019-2025)
9.3 Global Non-Opioid Pain Treatment Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Non-Opioid Pain Treatment Production
9.4.1 North America Non-Opioid Pain Treatment Production Growth Rate (2019-2025)
9.4.2 North America Non-Opioid Pain Treatment Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Non-Opioid Pain Treatment Production
9.5.1 Europe Non-Opioid Pain Treatment Production Growth Rate (2019-2025)
9.5.2 Europe Non-Opioid Pain Treatment Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Non-Opioid Pain Treatment Production (2019-2025)
9.6.1 Japan Non-Opioid Pain Treatment Production Growth Rate (2019-2025)
9.6.2 Japan Non-Opioid Pain Treatment Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Non-Opioid Pain Treatment Production (2019-2025)
9.7.1 China Non-Opioid Pain Treatment Production Growth Rate (2019-2025)
9.7.2 China Non-Opioid Pain Treatment Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Allergan PLC
10.1.1 Allergan PLC Non-Opioid Pain Treatment Basic Information
10.1.2 Allergan PLC Non-Opioid Pain Treatment Product Overview
10.1.3 Allergan PLC Non-Opioid Pain Treatment Product Market Performance
10.1.4 Allergan PLC Business Overview
10.1.5 Allergan PLC Non-Opioid Pain Treatment SWOT Analysis
10.1.6 Allergan PLC Recent Developments
10.2 Canopy Growth
10.2.1 Canopy Growth Non-Opioid Pain Treatment Basic Information
10.2.2 Canopy Growth Non-Opioid Pain Treatment Product Overview
10.2.3 Canopy Growth Non-Opioid Pain Treatment Product Market Performance
10.2.4 Canopy Growth Business Overview
10.2.5 Canopy Growth Non-Opioid Pain Treatment SWOT Analysis
10.2.6 Canopy Growth Recent Developments
10.3 Medical Marijuana Inc.
10.3.1 Medical Marijuana Inc. Non-Opioid Pain Treatment Basic Information
10.3.2 Medical Marijuana Inc. Non-Opioid Pain Treatment Product Overview
10.3.3 Medical Marijuana Inc. Non-Opioid Pain Treatment Product Market Performance
10.3.4 Medical Marijuana Inc. Non-Opioid Pain Treatment SWOT Analysis
10.3.5 Medical Marijuana Inc. Business Overview
10.3.6 Medical Marijuana Inc. Recent Developments
10.4 Panag Pharma Inc.
10.4.1 Panag Pharma Inc. Non-Opioid Pain Treatment Basic Information
10.4.2 Panag Pharma Inc. Non-Opioid Pain Treatment Product Overview
10.4.3 Panag Pharma Inc. Non-Opioid Pain Treatment Product Market Performance
10.4.4 Panag Pharma Inc. Business Overview
10.4.5 Panag Pharma Inc. Recent Developments
10.5 Tilray
10.5.1 Tilray Non-Opioid Pain Treatment Basic Information
10.5.2 Tilray Non-Opioid Pain Treatment Product Overview
10.5.3 Tilray Non-Opioid Pain Treatment Product Market Performance
10.5.4 Tilray Business Overview
10.5.5 Tilray Recent Developments
10.6 Aphria Inc.
10.6.1 Aphria Inc. Non-Opioid Pain Treatment Basic Information
10.6.2 Aphria Inc. Non-Opioid Pain Treatment Product Overview
10.6.3 Aphria Inc. Non-Opioid Pain Treatment Product Market Performance
10.6.4 Aphria Inc. Business Overview
10.6.5 Aphria Inc. Recent Developments
10.7 Bedrocan
10.7.1 Bedrocan Non-Opioid Pain Treatment Basic Information
10.7.2 Bedrocan Non-Opioid Pain Treatment Product Overview
10.7.3 Bedrocan Non-Opioid Pain Treatment Product Market Performance
10.7.4 Bedrocan Business Overview
10.7.5 Bedrocan Recent Developments
10.8 Cara Therapeutics
10.8.1 Cara Therapeutics Non-Opioid Pain Treatment Basic Information
10.8.2 Cara Therapeutics Non-Opioid Pain Treatment Product Overview
10.8.3 Cara Therapeutics Non-Opioid Pain Treatment Product Market Performance
10.8.4 Cara Therapeutics Business Overview
10.8.5 Cara Therapeutics Recent Developments
10.9 Centrexion Therapeutics
10.9.1 Centrexion Therapeutics Non-Opioid Pain Treatment Basic Information
10.9.2 Centrexion Therapeutics Non-Opioid Pain Treatment Product Overview
10.9.3 Centrexion Therapeutics Non-Opioid Pain Treatment Product Market Performance
10.9.4 Centrexion Therapeutics Business Overview
10.9.5 Centrexion Therapeutics Recent Developments
10.10 CHT Medical
10.10.1 CHT Medical Non-Opioid Pain Treatment Basic Information
10.10.2 CHT Medical Non-Opioid Pain Treatment Product Overview
10.10.3 CHT Medical Non-Opioid Pain Treatment Product Market Performance
10.10.4 CHT Medical Business Overview
10.10.5 CHT Medical Recent Developments
10.11 Cronos Group
10.11.1 Cronos Group Non-Opioid Pain Treatment Basic Information
10.11.2 Cronos Group Non-Opioid Pain Treatment Product Overview
10.11.3 Cronos Group Non-Opioid Pain Treatment Product Market Performance
10.11.4 Cronos Group Business Overview
10.11.5 Cronos Group Recent Developments
10.12 GW Pharmaceuticals
10.12.1 GW Pharmaceuticals Non-Opioid Pain Treatment Basic Information
10.12.2 GW Pharmaceuticals Non-Opioid Pain Treatment Product Overview
10.12.3 GW Pharmaceuticals Non-Opioid Pain Treatment Product Market Performance
10.12.4 GW Pharmaceuticals Business Overview
10.12.5 GW Pharmaceuticals Recent Developments
10.13 Medropharm Gmbh
10.13.1 Medropharm Gmbh Non-Opioid Pain Treatment Basic Information
10.13.2 Medropharm Gmbh Non-Opioid Pain Treatment Product Overview
10.13.3 Medropharm Gmbh Non-Opioid Pain Treatment Product Market Performance
10.13.4 Medropharm Gmbh Business Overview
10.13.5 Medropharm Gmbh Recent Developments
10.14 US Worldmeds LLC
10.14.1 US Worldmeds LLC Non-Opioid Pain Treatment Basic Information
10.14.2 US Worldmeds LLC Non-Opioid Pain Treatment Product Overview
10.14.3 US Worldmeds LLC Non-Opioid Pain Treatment Product Market Performance
10.14.4 US Worldmeds LLC Business Overview
10.14.5 US Worldmeds LLC Recent Developments
11 Non-Opioid Pain Treatment Market Forecast by Region
11.1 Global Non-Opioid Pain Treatment Market Size Forecast
11.2 Global Non-Opioid Pain Treatment Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Non-Opioid Pain Treatment Market Size Forecast by Country
11.2.3 Asia Pacific Non-Opioid Pain Treatment Market Size Forecast by Region
11.2.4 South America Non-Opioid Pain Treatment Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Non-Opioid Pain Treatment by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Non-Opioid Pain Treatment Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Non-Opioid Pain Treatment by Type (2025-2032)
12.1.2 Global Non-Opioid Pain Treatment Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Non-Opioid Pain Treatment by Type (2025-2032)
12.2 Global Non-Opioid Pain Treatment Market Forecast by Application (2025-2032)
12.2.1 Global Non-Opioid Pain Treatment Sales (K MT) Forecast by Application
12.2.2 Global Non-Opioid Pain Treatment Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Non-Opioid Pain Treatment Market Size Comparison by Region (M USD)
Table 5. Global Non-Opioid Pain Treatment Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Non-Opioid Pain Treatment Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Non-Opioid Pain Treatment Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Non-Opioid Pain Treatment Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Opioid Pain Treatment as of 2022)
Table 10. Global Market Non-Opioid Pain Treatment Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Non-Opioid Pain Treatment Sales Sites and Area Served
Table 12. Manufacturers Non-Opioid Pain Treatment Product Type
Table 13. Global Non-Opioid Pain Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Non-Opioid Pain Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non-Opioid Pain Treatment Market Challenges
Table 22. Global Non-Opioid Pain Treatment Sales by Type (K MT)
Table 23. Global Non-Opioid Pain Treatment Market Size by Type (M USD)
Table 24. Global Non-Opioid Pain Treatment Sales (K MT) by Type (2019-2025)
Table 25. Global Non-Opioid Pain Treatment Sales Market Share by Type (2019-2025)
Table 26. Global Non-Opioid Pain Treatment Market Size (M USD) by Type (2019-2025)
Table 27. Global Non-Opioid Pain Treatment Market Size Share by Type (2019-2025)
Table 28. Global Non-Opioid Pain Treatment Price (USD/MT) by Type (2019-2025)
Table 29. Global Non-Opioid Pain Treatment Sales (K MT) by Application
Table 30. Global Non-Opioid Pain Treatment Market Size by Application
Table 31. Global Non-Opioid Pain Treatment Sales by Application (2019-2025) & (K MT)
Table 32. Global Non-Opioid Pain Treatment Sales Market Share by Application (2019-2025)
Table 33. Global Non-Opioid Pain Treatment Sales by Application (2019-2025) & (M USD)
Table 34. Global Non-Opioid Pain Treatment Market Share by Application (2019-2025)
Table 35. Global Non-Opioid Pain Treatment Sales Growth Rate by Application (2019-2025)
Table 36. Global Non-Opioid Pain Treatment Sales by Region (2019-2025) & (K MT)
Table 37. Global Non-Opioid Pain Treatment Sales Market Share by Region (2019-2025)
Table 38. North America Non-Opioid Pain Treatment Sales by Country (2019-2025) & (K MT)
Table 39. Europe Non-Opioid Pain Treatment Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Non-Opioid Pain Treatment Sales by Region (2019-2025) & (K MT)
Table 41. South America Non-Opioid Pain Treatment Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Non-Opioid Pain Treatment Sales by Region (2019-2025) & (K MT)
Table 43. Global Non-Opioid Pain Treatment Production (K MT) by Region (2019-2025)
Table 44. Global Non-Opioid Pain Treatment Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Non-Opioid Pain Treatment Revenue Market Share by Region (2019-2025)
Table 46. Global Non-Opioid Pain Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Non-Opioid Pain Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Non-Opioid Pain Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Non-Opioid Pain Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Non-Opioid Pain Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Allergan PLC Non-Opioid Pain Treatment Basic Information
Table 52. Allergan PLC Non-Opioid Pain Treatment Product Overview
Table 53. Allergan PLC Non-Opioid Pain Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Allergan PLC Business Overview
Table 55. Allergan PLC Non-Opioid Pain Treatment SWOT Analysis
Table 56. Allergan PLC Recent Developments
Table 57. Canopy Growth Non-Opioid Pain Treatment Basic Information
Table 58. Canopy Growth Non-Opioid Pain Treatment Product Overview
Table 59. Canopy Growth Non-Opioid Pain Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Canopy Growth Business Overview
Table 61. Canopy Growth Non-Opioid Pain Treatment SWOT Analysis
Table 62. Canopy Growth Recent Developments
Table 63. Medical Marijuana Inc. Non-Opioid Pain Treatment Basic Information
Table 64. Medical Marijuana Inc. Non-Opioid Pain Treatment Product Overview
Table 65. Medical Marijuana Inc. Non-Opioid Pain Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Medical Marijuana Inc. Non-Opioid Pain Treatment SWOT Analysis
Table 67. Medical Marijuana Inc. Business Overview
Table 68. Medical Marijuana Inc. Recent Developments
Table 69. Panag Pharma Inc. Non-Opioid Pain Treatment Basic Information
Table 70. Panag Pharma Inc. Non-Opioid Pain Treatment Product Overview
Table 71. Panag Pharma Inc. Non-Opioid Pain Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Panag Pharma Inc. Business Overview
Table 73. Panag Pharma Inc. Recent Developments
Table 74. Tilray Non-Opioid Pain Treatment Basic Information
Table 75. Tilray Non-Opioid Pain Treatment Product Overview
Table 76. Tilray Non-Opioid Pain Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Tilray Business Overview
Table 78. Tilray Recent Developments
Table 79. Aphria Inc. Non-Opioid Pain Treatment Basic Information
Table 80. Aphria Inc. Non-Opioid Pain Treatment Product Overview
Table 81. Aphria Inc. Non-Opioid Pain Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Aphria Inc. Business Overview
Table 83. Aphria Inc. Recent Developments
Table 84. Bedrocan Non-Opioid Pain Treatment Basic Information
Table 85. Bedrocan Non-Opioid Pain Treatment Product Overview
Table 86. Bedrocan Non-Opioid Pain Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Bedrocan Business Overview
Table 88. Bedrocan Recent Developments
Table 89. Cara Therapeutics Non-Opioid Pain Treatment Basic Information
Table 90. Cara Therapeutics Non-Opioid Pain Treatment Product Overview
Table 91. Cara Therapeutics Non-Opioid Pain Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Cara Therapeutics Business Overview
Table 93. Cara Therapeutics Recent Developments
Table 94. Centrexion Therapeutics Non-Opioid Pain Treatment Basic Information
Table 95. Centrexion Therapeutics Non-Opioid Pain Treatment Product Overview
Table 96. Centrexion Therapeutics Non-Opioid Pain Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Centrexion Therapeutics Business Overview
Table 98. Centrexion Therapeutics Recent Developments
Table 99. CHT Medical Non-Opioid Pain Treatment Basic Information
Table 100. CHT Medical Non-Opioid Pain Treatment Product Overview
Table 101. CHT Medical Non-Opioid Pain Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. CHT Medical Business Overview
Table 103. CHT Medical Recent Developments
Table 104. Cronos Group Non-Opioid Pain Treatment Basic Information
Table 105. Cronos Group Non-Opioid Pain Treatment Product Overview
Table 106. Cronos Group Non-Opioid Pain Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Cronos Group Business Overview
Table 108. Cronos Group Recent Developments
Table 109. GW Pharmaceuticals Non-Opioid Pain Treatment Basic Information
Table 110. GW Pharmaceuticals Non-Opioid Pain Treatment Product Overview
Table 111. GW Pharmaceuticals Non-Opioid Pain Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. GW Pharmaceuticals Business Overview
Table 113. GW Pharmaceuticals Recent Developments
Table 114. Medropharm Gmbh Non-Opioid Pain Treatment Basic Information
Table 115. Medropharm Gmbh Non-Opioid Pain Treatment Product Overview
Table 116. Medropharm Gmbh Non-Opioid Pain Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Medropharm Gmbh Business Overview
Table 118. Medropharm Gmbh Recent Developments
Table 119. US Worldmeds LLC Non-Opioid Pain Treatment Basic Information
Table 120. US Worldmeds LLC Non-Opioid Pain Treatment Product Overview
Table 121. US Worldmeds LLC Non-Opioid Pain Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. US Worldmeds LLC Business Overview
Table 123. US Worldmeds LLC Recent Developments
Table 124. Global Non-Opioid Pain Treatment Sales Forecast by Region (2025-2032) & (K MT)
Table 125. Global Non-Opioid Pain Treatment Market Size Forecast by Region (2025-2032) & (M USD)
Table 126. North America Non-Opioid Pain Treatment Sales Forecast by Country (2025-2032) & (K MT)
Table 127. North America Non-Opioid Pain Treatment Market Size Forecast by Country (2025-2032) & (M USD)
Table 128. Europe Non-Opioid Pain Treatment Sales Forecast by Country (2025-2032) & (K MT)
Table 129. Europe Non-Opioid Pain Treatment Market Size Forecast by Country (2025-2032) & (M USD)
Table 130. Asia Pacific Non-Opioid Pain Treatment Sales Forecast by Region (2025-2032) & (K MT)
Table 131. Asia Pacific Non-Opioid Pain Treatment Market Size Forecast by Region (2025-2032) & (M USD)
Table 132. South America Non-Opioid Pain Treatment Sales Forecast by Country (2025-2032) & (K MT)
Table 133. South America Non-Opioid Pain Treatment Market Size Forecast by Country (2025-2032) & (M USD)
Table 134. Middle East and Africa Non-Opioid Pain Treatment Consumption Forecast by Country (2025-2032) & (Units)
Table 135. Middle East and Africa Non-Opioid Pain Treatment Market Size Forecast by Country (2025-2032) & (M USD)
Table 136. Global Non-Opioid Pain Treatment Sales Forecast by Type (2025-2032) & (K MT)
Table 137. Global Non-Opioid Pain Treatment Market Size Forecast by Type (2025-2032) & (M USD)
Table 138. Global Non-Opioid Pain Treatment Price Forecast by Type (2025-2032) & (USD/MT)
Table 139. Global Non-Opioid Pain Treatment Sales (K MT) Forecast by Application (2025-2032)
Table 140. Global Non-Opioid Pain Treatment Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Non-Opioid Pain Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-Opioid Pain Treatment Market Size (M USD), 2019-2032
Figure 5. Global Non-Opioid Pain Treatment Market Size (M USD) (2019-2032)
Figure 6. Global Non-Opioid Pain Treatment Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non-Opioid Pain Treatment Market Size by Country (M USD)
Figure 11. Non-Opioid Pain Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Non-Opioid Pain Treatment Revenue Share by Manufacturers in 2023
Figure 13. Non-Opioid Pain Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Non-Opioid Pain Treatment Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Non-Opioid Pain Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Non-Opioid Pain Treatment Market Share by Type
Figure 18. Sales Market Share of Non-Opioid Pain Treatment by Type (2019-2025)
Figure 19. Sales Market Share of Non-Opioid Pain Treatment by Type in 2023
Figure 20. Market Size Share of Non-Opioid Pain Treatment by Type (2019-2025)
Figure 21. Market Size Market Share of Non-Opioid Pain Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Non-Opioid Pain Treatment Market Share by Application
Figure 24. Global Non-Opioid Pain Treatment Sales Market Share by Application (2019-2025)
Figure 25. Global Non-Opioid Pain Treatment Sales Market Share by Application in 2023
Figure 26. Global Non-Opioid Pain Treatment Market Share by Application (2019-2025)
Figure 27. Global Non-Opioid Pain Treatment Market Share by Application in 2023
Figure 28. Global Non-Opioid Pain Treatment Sales Growth Rate by Application (2019-2025)
Figure 29. Global Non-Opioid Pain Treatment Sales Market Share by Region (2019-2025)
Figure 30. North America Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Non-Opioid Pain Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Non-Opioid Pain Treatment Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Non-Opioid Pain Treatment Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Non-Opioid Pain Treatment Sales Market Share by Country in 2023
Figure 37. Germany Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Non-Opioid Pain Treatment Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Non-Opioid Pain Treatment Sales Market Share by Region in 2023
Figure 44. China Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Non-Opioid Pain Treatment Sales and Growth Rate (K MT)
Figure 50. South America Non-Opioid Pain Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Non-Opioid Pain Treatment Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Non-Opioid Pain Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Non-Opioid Pain Treatment Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Non-Opioid Pain Treatment Production Market Share by Region (2019-2025)
Figure 62. North America Non-Opioid Pain Treatment Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Non-Opioid Pain Treatment Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Non-Opioid Pain Treatment Production (K MT) Growth Rate (2019-2025)
Figure 65. China Non-Opioid Pain Treatment Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Non-Opioid Pain Treatment Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Non-Opioid Pain Treatment Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Non-Opioid Pain Treatment Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Non-Opioid Pain Treatment Market Share Forecast by Type (2025-2032)
Figure 70. Global Non-Opioid Pain Treatment Sales Forecast by Application (2025-2032)
Figure 71. Global Non-Opioid Pain Treatment Market Share Forecast by Application (2025-2032)
